segunda-feira, 31 de outubro de 2011
Vencedores do Concurso Minuto Científico
sábado, 29 de outubro de 2011
Sugestões de temas da Semana Nacional de CT 2012
sexta-feira, 28 de outubro de 2011
Como alcançar seu próprio "lugar" na ciência? Um comentário divertido e oportuno no Sciencemag de hoje.
A crônica inteligente e divertida de Adam Ruben fala de uma preocupação cada vez mais inquietante entre os jovens cientistas: como conseguir a sonhada carreira científica devidamente empregado em uma instituição com direito aos benefícios trabalhistas "como todo mundo..." Texto reproduzido abaixo, Confira!
Experimental Error: OMG, So Many Science Careers
- Academic scientist
- If you like grant writing, writing grants, and obtaining grants via writing, you may enjoy life as an academic scientist. You’ll also experience the thrill of teaching overly broad, university-mandated survey courses (“Introduction to Biology, Chemistry, and Physics Without Algebra”), flexible work hours (You work 22 hours a day, but you pick the 22 hours!), and doing the Tenure Tango (“You put your left foot in, you take your left foot out, you put your left foot in the grave.”).
- Industry scientist, large biotech/pharma
- Academics often say disdainfully that you need a certain quality to work at a large biotech or pharmaceutical company, and that quality is evil. Apparently only evil people apply their skills to solve real-world problems, and only evil people are paid well.
- Industry scientist, small biotech/pharma
- That’s me! As an employee at a startup biotech company, I face the daily excitement of knowing that my job is so cutting-edge that it might not exist in a year. Now that’s cutting-edge!
- Consultant
- A consultant’s job is to tell other people what they’re doing wrong. (In this way, my wife is a consultant. Zing!) A lot of consulting firms have been hiring scientists lately because of our problem-solving skills, our ability to analyze large datasets, and because they’re slowly realizing that all the MBAs they hired are just morons with nice hair.
- Government scientist
- Working as a government scientist is a great idea, because the government is really popular right now. Read any newspaper and you’ll see stories about how much people love and trust the government.
- Law
- Every scientist has that friend from graduate school who graduated and then announced, “I’m going to law school!” and we all wept a little inside. Why would someone who worked in science find anything exciting aboutlaw? Why would someone who spent 7 years earning a Ph.D. want to go back to school? Did he or she wake up one day and say, “I don’t think I’m carrying enough debt! Is there a way I can fix this while still delaying adulthood for a few years?”
- Military science
- Okay, here’s what drives me nuts. Several times, I’ve visited my scientific collaborators in the Army or Navy, and they’re always wearing camouflage in the lab. Desert camouflage. Beige, with little squares of off-beige. But the lab is, you know, indoors, and white. And they have all kinds of weird rules about when they are and aren’t supposed to wear their hats.
- Adjunct teaching
- Ah, the free life of an adjunct instructor! Adjuncting offers freedom from the tenure struggle, freedom from the stifling responsibilities of a full-time professor, and freedom from the burden of income. As an adjunct, you’ll bounce among the local colleges, teaching classes on six different campuses a day, but you’ll know that you no longer have to worry about pointless things like research -- all that matters is whether you can convince a classroom of 18-year-olds not to plagiarize their take-home exams. (You can’t.)
- Science advocacy
- Let’s face it: Scientists aren’t great at expressing themselves. We end up saying things like, “Hepatitis kills over 1 million people every year. THEREFORE GIVE ME MONEY TO BUILD A MECHANIZED KANGAROO WITH LASERS.” That’s why there are science advocates, people who explain to nonscientists why we matter. And if I have to explain why that’s important, I guess that makes me a science advocate advocate.
- Science policy
- Unlike a consulting firm, which overpays you to advise wealthy companies to rely too heavily on your minimally informed advice, a job in science policy will pay you to advise lawmakers who’ll ignore you. “We value your advice!” they’ll tell you, then go vote against the laws of thermodynamics.
- Found your own startup
- Finally, if you don’t like the science jobs out there, make your own! First, give your company a slick name that says nothing about what you do, like “Slick Technologies” or “Digital Goose Inc.” Next, come up with a meaningless slogan, such as, “Managing your outflow from within,” or “Where technology and people meet the 21st century … with deliverables.” Then sit back and wait for a large company to buy yours -- because your startup may not actually do anything, but what you don’t do is so confusing that they’d rather buy you than risk letting you do things.
quinta-feira, 27 de outubro de 2011
Best Places to Work is Back
Take the postdoc survey now! | Take the academia survey now! | Take the industry survey now! |
Veja a metodologia:
Survey Methodology
- Quality of Training and Mentoring
- Career Development Opportunities and Networking
- Quality of Communication
- Value of the Postdoc Experience
- Quality of Facilities and Infrastructure
- Funding
- Equity
- Pay and Benefits
- Family and Personal Life
- The sample of respondents, while large, was self-selected, which may introduce some bias into the results.
- The scoring of results is not standardized, and standards may fluctuate between individuals, institutions, and countries.
- In some cases, small sample responses may have led to bias in the results.
- No attempt has been made to measure the statistical significance of the results. The difference between, say a 10th-ranked and a 15th-ranked institution may be insignificant.
quarta-feira, 26 de outubro de 2011
Falecimento de Frank Neva
Wednesday, Oct. 26, 2011 Media Contact: NIAID Office of Communications
(301) 402-1663
niaidnews@niaid.nih.gov NIH Remembers Dr. Franklin A. Neva Franklin A. Neva, M.D., a renowned virologist, parasitologist, clinician and former chief of the Laboratory of Parasitic Diseases at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, died on Oct. 15, 2011. He was 89 years old.
Dr. Franklin A. Neva <http://niaid.pr-optout.com/Url.aspx?521095x626367x-148315>
"Frank Neva was an exceptional scientist and clinician who established a pioneering biomedical research program focused on the interactions between humans and parasites," said NIAID Director Anthony S. Fauci, M.D. "He built the NIAID Laboratory of Parasitic Diseases into a world-class team, hiring and training future leaders in clinical parasitology for more than 30 years. He was widely admired as a person, mentor, clinician and scientist, and he will be greatly missed."
After medical school and an internship, Dr. Neva began his research career in 1947, studying typhoid fever and schistosomiasis at Naval Medical Research Unit-3 in Cairo. He then spent three years at Harvard University, Cambridge, Mass., where he first described Boston exanthem disease, an echovirus infection in children characterized by mild fever and widespread rash. After an academic appointment in the laboratory of Dr. Jonas Salk at the University of Pittsburgh, Dr. Neva returned to Harvard to work in the newly created Department of Tropical Public Health. In 1962 he and Dr. Thomas Weller co-discovered rubella virus, the cause of German measles. An independent group at the Walter Reed Army Institute for Research, Washington, D.C., also isolated the virus around the same time.
Dr. Neva was recruited to NIAID in 1969 to become chief of the NIAID Laboratory of Parasitic Diseases (LPD). He helped coalesce LPD research sections scattered from Hawaii to Georgia to Bethesda, Md., and from the beginning, he emphasized research on the biology of parasites as well as on the human immune responses to parasitic infections. In 1971, he hired Dr. Louis Miller, who established a highly productive malaria research laboratory and later succeeded Dr. Neva as chief of LPD.
"Frank was brought to NIH to revitalize the Laboratory of Parasitic Diseases, and he did just that," said Dr. Miller, who currently is a section chief in the NIAID Laboratory of Malaria and Vector Research. "He knew how to bring out the best in his staff and was deeply respected by all of us."
Dr. Neva hired many future NIH leaders of tropical disease research, such as Drs. Tom Wellems, Tom Nutman, David Sacks, Ted Nash and Alan Sher. In doing so he shepherded the growth of parasitology research at NIH from a small area of focus to a program that is now spread among four different NIAID laboratory groups and involves about 400 NIAID scientific staff at laboratories in Bethesda and overseas.
Dr. Neva also established a clinical service for parasitic infections at NIH, which treats patients from developing countries as well as U.S. citizens whose cases are of scientific interest. He mentored many LPD trainees who subsequently rose to leadership positions in universities, government agencies and international health organizations.
"Frank made major contributions to the study of malaria, leishmaniasis, Chagas disease and strongyloidiasis," said Dr. Nash, an LPD section chief and Dr. Neva's first research fellow. "His great love was clinical parasitology," Dr. Nash said. "There was no one better clinically. I most appreciated his integrity, humility and unselfishness-traits he used to make considered decisions for the benefit of his staff."
Among his many honors, Dr. Neva was the first member of the American Society of Tropical Medicine and Hygiene (ASTMH) to receive its Ben Kean Medal, an award that recognized his dedication to clinical tropical medicine and his impact on the training of students, fellows and practitioners of tropical medicine. He also received the ASTMH Donald Mackay Medal, a highly selective recognition for outstanding work in tropical health relating to improvements in the health of rural or urban workers in the tropics; the ASTMH Bailey K. Ashford Medal for distinguished work in tropical medicine early in his career; the Joseph E. Smadel Lectureship from the Infectious Diseases Society of America; and the Presidential Meritorious Executive Rank Award for his exemplary leadership and public service.
terça-feira, 25 de outubro de 2011
WORLDLEISH NO BRASIL!!!!
Congratulations ! This outcome results mainly from the choice by the majority of the Scientific Committee members and, in part, from default (see point 2). The applicants are requested to provide a detailed plan to address all points of the concerns raised by the Scientific Committee members and kindly provided by other leishmaniacs (see List provided). Their comments and suggestions are posted for your reference. The organizers’ response to the issues raised by the evaluators will be announced on November 1st, 2011.
Leishmaníacos, atenção! Em 2013, teremos o congresso mundial em nossas maravilhosas paisagens!!! Este é O evento para quem trabalha na área e quer conhecer os experts e ter uma boa visão do que anda se fazendo por aí.
sexta-feira, 21 de outubro de 2011
'Dance Your Ph.D.' Winner Announced
"The rules of the contest were simple: Each dance had to be based on a scientist's Ph.D. research, and that scientist had to be part of the dance. A record 55 dances were submitted to this year's contest, covering everything from psychology to astrophysics. Last week, 16 finalists were chosen by six previous winners of the contest. The finalists were then scored by a panel of judges that included scientists from Harvard University, the Massachusetts Institute of Technology, and Boston University, as well as choreographers from Pilobolusand the entire dance cast of Shadowland."
Coloquei abaixo o vídeo mais relacionado com o trabalho do laboratório.
Dance your PhD 2011: Smell mediated response to relatedness of potential mates from Cedric Kai Wei Tan on Vimeo.
Blog do LIMI e LIP com mais acessos no Rio que em Salvador
Para mim, foi uma surpresa. Havia visto isto há alguns dias e pensei ser algo temporário. Constato agora que permanece e, ademais, São Paulo está tão próximo que Salvador pode vir a ser a terceira cidade em acesso em pouco tempo.
A tabela abaixo indica os acessos de 20 de setembro a 20 de outubro.
Em relação aos 30 dias anteriores, os acessos do Rio cresceram de 250 para os quase trezentos atuais. Nesta mesma comparação, os acessos oriundos de Salvador passaram de 405 para 267.
Excelente que outras cidades estejam interessadas no conteúdo do blog, mas por que o público-alvo direto perdeu interesse?
quarta-feira, 19 de outubro de 2011
RAIC 2011 - Alunos do ensino médio apresentam seus projetos
Eliane: Para mim esta bolsa proporcionou a oportunidade de ampliar meus conhecimentos sobre a biologia sobre resposta imunológica e tantos outros conhecimentos , despertando nosso censo crítico em relação a ciência de aprender coisas novas nos concedendo a oportunidade de nos realizarmos tanto pessoalmente como intelectualmente. Por isto eu estou muito feliz com essa bolsa que foi a mim concedida.
Workshop CAT/CEPID "Cell Cycle mechanisms and Cell Survival
Auditório do Museu Biológico
São Paulo - SP
Cell Cycle mechanisms and Cell Survival
Programa
8:45 – 9:30: M Carolina Elias
(Laboratório Especial de Ciclo Celular, Centro Aplicado de Toxinologia, Instituto Butantan, São Paulo, Brasil)
Opening Section
Searching for the control of DNA replication in Trypanosomas
9:30 – 10:20: Rafael Linden
(Instituto de Biofísica, Universidade Federal do Rio de Janeiro, Brasil)
Control of the cell cycle: a lesson from retinal progenitor cells
10:20 - 10:40: Coffe Break
10:40 - 11:30: Luc Pellerin
(Department of Cell Biology and Morphology, /university of Lausanne, Switzerland)
Cerebral metabolic plasticity: adjusting energetic supply via regulation of monocarboxylate transporters
11:30 - 11:45: Miryam Paola Alvarez Flores
(Laboratório de Bioquímica,Instituto Butantan, São Paulo, Brasil)
A cell adhesion molecule from Lonomia obliqua caterpillar trigger cell viability through the activation of survival pathways and gene expression
12:00 - 14:00: Lunch
14:00 - 14:50: Bruno Robbs
(Instituto Nacional do Câncer, Rio de Janeiro, Brasil)
NFAT transcription factors in the regulation of cell cycle and deat
14:50 - 15:40: Yi-Jun Sheu
(Cold Spring Harbor Laboratory, NY, USA)
Control of chromosomal DNA replication by kinase signaling pathway in eukaryotic cells
15:40 - 16:00: Coffe Break
16:00 - 16:30: Bruno Dallagiovanna
(Instituto Carlos Chagas, FIOCRUZ, Curitiba)
Posttranscriptional gene networks in the control of adult stem cell proliferation
16:30 - 17:00: Matheus Henrique dos Santos Dias
(Laboratório Especial de Ciclo Celular, Centro Aplicado de Toxinologia, Instituto Butantan, São Paulo, Brasil)
FGF2 targets an Achilles' heel of ras-driven mouse malignant cells.
terça-feira, 18 de outubro de 2011
http://www.cellimagelibrary.org/
segunda-feira, 17 de outubro de 2011
II Workshop da Rede TB no Rio de Janeiro: inscrições abertas até 20 de outubro
Data: 21, 22, 23 de novembro de 2011
Local: Universidade Gama Filho, campus Downtown - Barra da Tijuca, Rio de Janeiro
Inscrição:
até 20 de outubro - data limite para enviar trabalhos
Profissional não sócio - R$280,00 - Profissional sócio da Rede TB - R$200,00
Estudantes de PG e Graduação não sócio - R$150,00 - Estudante Sócio R$70,00
após 20 de outubro
Profissional não sócio - R$380,00 - Profissional sócio da Rede TB - R$300,00
Estudantes de PG e Graduação não sócio - R$230,00 - Estudante Sócio R$150,00
Banco Itaú
Rede Brasleira de Pesquisas em Tuberculose - CNPJ 05.844.523/0001-38
Agência: 0370
Conta corrente: 63130-1
Favor escanear o recibo da inscrição e enviar para Leila Fonseca,
lsfonseca46@gmail.com
Em caso de dúvidas e/ou para mais informações favor escrever para lsfonseca46@gmail.com
quarta-feira, 12 de outubro de 2011
Gene Network Analysis of Bone Marrow Mononuclear Cells Reveals Activation of Multiple Kinase Pathways in Human Systemic Lupus Erythematosus
Post de Marcia Weber Carneiro (LIP-CPqGM/FIOCRUZ)
O estudo do perfil genético fornece informações importantes sobre moléculas chaves relevantes para doenças, porém não são muito informativos sobre as interações entre proteínas, sobre modificações pós-traducionais e sobre a regulação de alvos subcelulares. Assim, a integração de dados genônimos e a construção de teias funcionais de genes fornece uma hipóteses para doenças complexas como o lúpus sistêmico eritematoso (SLE). O SLE é uma doença que afeta múltiplos órgãos e se caracteriza por períodos de remissão e de extensão. Apesar de sua etiologia não estar bem definida, muitos caminhos patogênicos contribuem para injúria tecidual.
Para este estudo, os autores avaliaram a expressão gênica em células mononucleares da medula óssea de pacientes com SLE ativa, inativa e de indivíduos controle utilizando a técnica de microarranjos. Para a construção das redes, foi utilizada a ferramenta de bioinformática Análise de Rede de Genes Ingenuity.
A análise comparativa de pacientes com SLE e controles revelou uma rede com 19 moléculas centrais como principais reguladoras incluindo ERK, JNK, e p38 MAP quinases, insulina, Ca2+ e STAT3. Já a comparação de pacientes com SLE ativa e inativa identificou 30 moléculas centrais associadas com resposta imune, síntese de proteínas e modificação pós-traducional. Um alto grau de identidade entre pacientes com SLE ativa e com linfoma de Hodgkin’s foi encontrado, com moléculas centrais sobrepostas incluindo quinases (MAPK, ERK, JNK, PKC), fatores de transcrição (NF-kappaB, STAT3), e insulina. Para a validação dos achados foi realizada a análise por Western Blot de células B do baço de camundongos com lúpus. Estes animais apresentaram ativação de STAT3, ITGB2, HSPB1, ERK, JNK, p38, e p32 kinases, e inibição de FOXO3 e VDR quando comparados com animais controle.
Com isso, autores concluem que a rede de análise de genes expressos em pacientescom lúpus foi capaz de identificar genes centrais na regulação da patogênese que podem representar alvos para novas terapias na SLE humana. A alta similaridade entre SLE ativa e linfoma de Hogdkin fornece uma base molecular para a associação encontrada da mesma com malignidades linfóides. Deste modo, a análise de redes de genes baseada em dados de expressão gênica é um método poderoso para prever reguladores gênicos chaves e para identificar redes compartilhadas entre categorias distintas de doenças complexas.
Nakou M, Bertsias G, Stagakis I, Centola M, Tassiulas I, Hatziapostolou M, Kritikos I, Goulielmos G, Boumpas DT, & Iliopoulos D (2010). Gene network analysis of bone marrow mononuclear cells reveals activation of multiple kinase pathways in human systemic lupus erythematosus. PloS one, 5 (10) PMID: 20976278